Autoantibodies targeting TLR and SMAD pathways define new subgroups in systemic lupus erythematosus

These data suggest that the novel SLE autoantibody clusters may be of prognostic utility for predicting organ involvement in SLE patients and for stratifying SLE patients for specific therapies.